Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

86.37
Delayed Data
As of Oct 16
 +0.24 / +0.28%
Today’s Change
66.93
Today|||52-Week Range
86.90
+18.57%
Year-to-Date
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
Non-Alcoholic Steatohepatitis 2017 Progress Update
Oct 12 / Zacks.com - Paid Partner Content
Let's Talk About CAR-T
Oct 16 / GuruFocus News - Paid Partner Content
Adirondack Trust Co Buys Arrow Financial Corp, Consolidated Edison Inc, Ambev SA, Sel...
Oct 12 / GuruFocus News - Paid Partner Content
Bristol-Myers (BMY), TARGET Extend Partnership for NASH Study
Oct 13 / Zacks.com - Paid Partner Content
Lilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study
Oct 11 / Zacks.com - Paid Partner Content
Lilly's Verzenio Gets Priority Review in First-Line Setting
Oct 13 / Zacks.com - Paid Partner Content
5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings
Oct 10 / Zacks.com - Paid Partner Content
FDA Advisory Committee Greenlights First Gene Therapy for Inherited Disorder
Oct 12 / TheStreet.com - Paid Partner Content
Ledyard National Bank Buys ABB, JM Smucker Co, Novartis AG, Sells Marriott Internatio...
Oct 10 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close86.13
Today’s open86.35
Day’s range86.19 - 86.87
Volume857,876
Average volume (3 months)1,667,295
Market cap$201.8B
Dividend yield3.15%
Data as of 4:02pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)-61.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.63%
Revenue growth (last year)-1.90%
P/E ratio31.5
Price/Sales3.61
Price/Book2.71

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.36-0.99%
MRKMerck-0.05-0.08%
SNYSanofi+0.14+0.28%
ABBVAbbVie+0.37+0.41%
Data as of 4:02pm ET, 10/16/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$1.23
Annual revenue (last year)$48.4B
Annual profit (last year)$6.7B
Net profit margin13.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts